COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated disease COVID-19. Clinicians are continuously facing huge problems in the treatment of patients, as COVID-19-specific drugs are not available, hence the principle of drug repurposing serves as a one-and-only hope. Gl...

Full description

Bibliographic Details
Main Authors:	Sunny Kumar, Malini Basu, Pratyasha Ghosh, Uttam Pal, Mrinal K. Ghosh
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-07-01
Series:	Genes and Diseases
Subjects:	Clinical trials COVID-19 Drug discovery Pharmacology Repurposing of drugs SARS-CoV-2
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223000211

Similar Items

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
by: Mario Roberto Senger, et al.

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
by: Pawan Kumar Raghav, et al.
Published: (2023-05-01)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
by: Shraddha M. Dalwadi, et al.
Published: (2023-05-01)

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
by: Liliana Rodrigues, et al.
Published: (2022-04-01)

Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
by: Rajkumar Singh Kalra, et al.
Published: (2022-12-01)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
by: Mithun Rudrapal, et al.
Published: (2022-12-01)

An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
by: Luca Menestrina, et al.
Published: (2022-12-01)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01)

Target-specific compound selectivity for multi-target drug discovery and repurposing
by: Tianduanyi Wang, et al.
Published: (2022-09-01)

Editorial: Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
by: Pan Zheng, et al.
Published: (2023-11-01)

Network bioinformatics analysis provides insight into drug repurposing for COVID-19
by: Xu Li, et al.
Published: (2021-06-01)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
by: Ashour NA, et al.
Published: (2022-03-01)

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021-03-01)

Emerging target discovery and drug repurposing opportunities in chordoma
by: Daniel M. Freed, et al.
Published: (2022-10-01)

Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
by: Guillermo de Anda-Jáuregui, et al.
Published: (2018-03-01)

Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
by: Smruti Sudha Nayak, et al.
Published: (2023-04-01)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
by: Lalu Muhammad Irham, et al.
Published: (2022-12-01)

Human coronaviruses and therapeutic drug discovery
by: Lan-Gui Song, et al.
Published: (2021-03-01)

Strategies for drug repurposing against coronavirus targets
by: Poppy O. Smith, et al.
Published: (2022-01-01)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
by: Eric March-Vila, et al.
Published: (2017-05-01)

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
by: Trang T. T. Truong, et al.
Published: (2022-07-01)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
by: Laura Chaffey, et al.
Published: (2022-10-01)

Drug repurposing and prediction of multiple interaction types via graph embedding
by: E. Amiri Souri, et al.
Published: (2023-05-01)

Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
by: Ahmed A. Al-Karmalawy, et al.
Published: (2021-11-01)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
by: Takeshi Tanaka, et al.
Published: (2022-01-01)

Computational Drug Repurposing Using Power Graph Analysis of Integrated Drug-Target-Disease Network
by: P. H. Nishamol, et al.
Published: (2023-01-01)

Cardiovascular/anti‐inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta‐analysis of randomized trials
by: David J. Benjamin, et al.
Published: (2024-03-01)

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis
by: Bernardo Pereira Moreira, et al.
Published: (2022-02-01)

A Database of Drug Repurposing Clinical Trials in Oncology
by: Pan Pantziarka, et al.
Published: (2021-11-01)

Use of repurposed drugs in COVID-19 pandemic: Old drugs without new tricks?
by: Suraj Kapoor
Published: (2023-01-01)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
by: Exequiel O. J. Porta, et al.
Published: (2023-07-01)

Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
by: Melissa Alegría-Arcos, et al.
Published: (2022-08-01)

Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy
by: Yan Zhang, et al.
Published: (2020-03-01)

Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
by: Dinorah Gambino
Published: (2023-02-01)

Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01)

Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
by: William Mangione, et al.
Published: (2022-08-01)

Screening of GPCR drugs for repurposing in breast cancer
by: Noor Mazin Abdulkareem, et al.
Published: (2022-12-01)